| 2023 | An Untapped Window of Opportunity for Glioma: Targeting Therapy-Induced Senescence Prior to Recurrence. Terry Burns, Cecile Riviere-Cazaux, Lucas Carlstrom, Bryan Neth, Ian Olson, Karishma Rajani, Masum Rahman, Samar Ikram, Moustafa Mansour, Bipasha Mukherjee, Arthur Warrington, Susan Short, Desmond Brown, Sandeep Burma, Tamara Tchkonia, Marissa Schafer, Darren Baker, Sani Kizilbash, James Kirkland, and Thomas von Zglinicki. npj Precision Oncology. 2023 Oct. In press |
| 2023 | Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair. Wang M, Li W, Tomimatsu N, Yu CH, Ji JH, Alejo S, Witus SR, Alimbetov D, Fitzgerald O, Wu B, Wang Q, Huang Y, Gan Y, Dong F, Kwon Y, Sareddy GR, Curiel TJ, Habib AA, Hromas R, Dos Santos Passos C, Yao T, Ivanov DN, Brzovic PS, Burma S, Klevit RE, Zhao W. Mol Cell. 2023 Sep 29:S1097-2765(23)00734-7 |
| 2023 | Structural insights into BCDX2 complex function in homologous recombination. Rawal Y, Jia L, Meir A, Zhou S, Kaur H, Ruben EA, Kwon Y, Bernstein KA, Jasin M, Taylor AB, Burma S, Hromas R, Mazin AV, Zhao W, Zhou D, Wasmuth EV, Greene EC, Sung P, Olsen SK. Nature. 2023 Jul;619(7970):640-649 |
2023
| EEPD1 promotes repair of oxidatively-stressed replication forks. Jaiswal AS, Kim HS, Schärer OD, Sharma N, Williamson EA, Srinivasan G, Phillips L, Kong K, Arya S, Misra A, Dutta A, Gupta Y, Walter CA, Burma S, Narayan S, Sung P, Nickoloff JA, Hromas R. NAR Cancer. 2023 Jan 18;5(1):zcac044. |
| 2023 | DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation. Kwon Y, Rösner H, Zhao W, Selemenakis P, He Z, Kawale AS, Katz JN, Rogers CM, Neal FE, Badamchi Shabestari A, Petrosius V, Singh AK, Joel MZ, Lu L, Holloway SP, Burma S, Mukherjee B, Hromas R, Mazin A, Wiese C, Sørensen CS, Sung P.Nat Commun. 2023 Jan 26;14(1):432. |
| 2022 | Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models. Li F, Bondra KM, Ghilu S, Studebaker A, Liu Q, Michalek JE, Kogiso M, Li XN, Kalapurakal JA, James CD, Burma S, Kurmasheva RT, Houghton PJ. Clin Cancer Res. 2022 Sep 1;28(17):3836-3849. |
| 2022 | Bloom helicase mediates formation of large single-stranded DNA loops during DNA end processing. Xue C, Salunkhe SJ, Tomimatsu N, Kawale AS, Kwon Y, Burma S, Sung P, Greene EC. Nat Commun. 2022 Apr 26;13(1):2248. |
| 2022 | Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition. Rahman M, Olson I, Mansour M, Carlstrom LP, Sutiwisesak R, Saber R, Rajani K, Warrington AE, Howard A, Schroeder M, Chen S, Decker PA, Sananikone EF, Zhu Y, Tchkonia T, Parney IF, Burma S, Brown D, Rodriguez M, Sarkaria JN, Kirkland JL, Burns TC. Mol Cancer Res. 2022 Jun 3;20(6):938-948 |
| 2022 | Targeting radioresistance and replication fork stability in prostate cancer. Li X, Baek G, Carreira S, Yuan W, Ma S, Hofstad M, Lee S, Gao Y, Bertan C, Fenor de la Maza MLD, Alluri PG, Burma S, Chen BP, Raj GV, de Bono J, Pommier Y, Mani RS. JCI Insight. 2022 May 9;7(9):e152955. |
| 2022 | EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation. Guo G, Gong K, Beckley N, Zhang Y, Yang X, Chkheidze R, Hatanpaa KJ, Garzon-Muvdi T, Koduru P, Nayab A, Jenks J, Sathe AA, Liu Y, Xing C, Wu SY, Chiang CM, Mukherjee B, Burma S, Wohlfeld B, Patel T, Mickey B, Abdullah K, Youssef M, Pan E, Gerber DE, Tian S, Sarkaria JN, McBrayer SK, Zhao D, Habib AA. Nat Cell Biol. 2022 Aug;24(8):1291-1305. |
| 2021 | Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids. Gong K, Guo G, Beckley NA, Yang X, Zhang Y, Gerber DE, Minna JD, Burma S, Zhao D, Akbay EA, Habib AA. Nat Commun. 2021 Dec 1;12(1):7014. |
| 2021 | Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy. Prasanna PG, Citrin DE, Hildesheim J, Ahmed MM, Venkatachalam S, Riscuta G, Xi D, Zheng G, Deursen JV, Goronzy J, Kron SJ, Anscher MS, Sharpless NE, Campisi J, Brown SL, Niedernhofer LJ, O'Loghlen A, Georgakilas AG, Paris F, Gius D, Gewirtz DA, Schmitt CA, Abazeed ME, Kirkland JL, Richmond A, Romesser PB, Lowe SW, Gil J, Mendonca MS, Burma S, Zhou D, Coleman CN. J Natl Cancer Inst. 2021 Oct 1;113(10):1285-1298. |
| 2021 | Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence Fletcher-Sananikone E, Kanji S, Tomimatsu N, Di Cristofaro LFM, Kollipara RK, Saha D, Floyd JR, Sung P, Hromas R, Burns TC, Kittler R, Habib AA, Mukherjee B, Burma S. Cancer Res. 2021 Dec 1;81(23):5935-5947 |
| 2020 | Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells. Lafita-Navarro MC, Venkateswaran N, Kilgore JA, Kanji S, Han J, Barnes S, Williams NS, Buszczak M, Burma S, Conacci-Sorrell M. PLoS Genet. 2020 Nov 17;16(11):e1009117. |
| 2020 | Specificity of end resection pathways for double-strand break regions containing ribonucleotides and base lesions. Daley JM, Tomimatsu N, Hooks G, Wang W, Miller AS, Xue X, Nguyen KA, Kaur H, Williamson E, Mukherjee B, Hromas R, Burma S, Sung P. Nat Commun. 2020 Jun 18;11(1):3088. |
| 2020 | EGFR inhibition triggers an adaptive response driven by cooptation of antiviral signaling pathways in lung cancer. K. Gong, G. Guo, S. Panchani, M. Bender, D.E. Gerber, J.D. Minna, F. Fattah, B. Gao, M. Peyton, K. Kernstine, B. Mukherjee, S. Burma, C.M. Chiang, Z. Zhang, A.A. Sathe, C. Xing, K.H. Dao, D. Zhoa. E.A. Akbay, and A.A. Habib Nature Cancer (2020)
|
| 2019 | Radiation-induced DNA damage cooperates with heterozygosity of TP53 and PTEN to generate high-grade gliomas. P.K. Todorova, E. Fletcher-Sananikone, B. Mukherjee, R. Kollipara, V. Vemireddy, X.J. Xie, P. Guida, M.D. Story, K.J. Hatanpaa, A.A. Habib, R. Kittler, R.M. Bachoo, R. Hromas, J. Floyd, and S. Burma Cancer Research 79:3749-3761 (2019) |
| 2019 | MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers. G. Srinivasan, E.A. Williamson, K. Kong, A.S. Jaiswal, G. Huang, H.S. Kim, O. Schärer, W. Zhao, S. Burma, P. Sung, and R. Hromas Proc Natl Acad Sci U S A. 116:17438-17443 (2019) |
| 2019 | Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma. G. Guo, K. Gong, V.T. Puliyapaddamba, N. Panchani, E. Pan, B. Mukherjee, Z. Damanwalla, S. Bharia, K.J. Hatanpaa, D. E. Gerber, B.E. Mickey, T.R. Patel, J.N. Sarkaria, D. Zhao, S. Burma, and A.A. Habib Neuro Oncology (2019) [Epub ahead of print] |
| 2018 | TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer. K. Gong, G. Guo, D.E. Gerber, B. Gao, M. Peyton, C. Huang, J.D. Minna, K.J. Hatanpaa, K. Kernstine, L. Cai, Y. Xie, H. Zhu, F.J. Fattah, S. Zhang, M. Takahashi, B. Mukherjee, S. Burma, J. Dowell, K. Dao, V.A. Papadimitrakopoulou, V. Olivas, T.G. Bivona, M. Ma, K. Politi, D. Zhao, and A. A. Habib Journal of Clinical Investigation 128:2500-2518 (2018) |
| 2018 | BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer. X. Li, G-H. Baek, S.G. Ramanand, A. Sharp, Y. Gao, W. Yuan, J. Welti, D.N. Rodrigues, D. Dolling, I. Figueiredo, S. Sumanasuriya, M. Crespo, A. Aslam, R. Li, Y. Yin, B. Mukherjee, M. Kanchwala, A.M. Hughes, W.S. Halse, C-M. Chiang, C Xing, G.V. Raj, S. Burma, J. de Bono, and R.S. Mani Cell Reports 22:796-808 (2018) |
| 2017 | A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma. G. Guo, K. Gong, S. Ali, N. Ali, S. Shallwani, K.J. Hatanpaa, E. Pan, B. Mickey, S. Burma, S. Kesari, Dawen Zhao, and A.A. Habib Nature Neuroscience 8:1074-1084 (2017) |
| 2017 | EGFR mutations compromise hypoxia-associated radiation resistance through impaired replication fork–associated DNA damage repair. M. Saki, H. Makino, P. Javvadi, N. Tomimatsu, L. Ding, J. Clark, E. Gavin, K. Takeda, J. Andrews, D. Saha, M.D. Story, S. Burma, and C. Nirodi Molecular Cancer Research 22:796-808 (2017) |
| 2017 | Androgen receptor variants mediate DNA repair after prostate cancer irradiation. Y. Yin, R. Li, K. Xu, S. Ding, J. Li, G.H. Baek, S. Ramanand, S. Ding, Z. Liu, Y. Gao, M. Kanchwala, X. Li, R. Hutchinson, X. Liu, S. Woldu, C. Xing, N. Desai, F. Feng, S. Burma, J. de Bono, S. Dehm, R. Mani, B. Chen, and G. Raj Cancer Research 77:4745-4753 (2017) |
| 2017 | DNA-damage-induced degradation of EXO1 exonuclease limits DNA end resection to ensure accurate DNA repair. N. Tomimatsu, B. Mukherjee, J.L. Harris, F.L. Boffo, M. Hardebeck, P.R. Potts, K.K. Khanna, and S. Burma Journal of Biological Chemistry 292:10779-10790 (2017) |
| 2017 | Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae. M. Kalimutho, A. L. Bain, B. Mukherjee, P. Nag, D.M. Nanayakkara, S.K. Harten, J.L. Harris, G.N. Subramanian, D. Sinha, S. Shirasawa, S. Srihari, S. Burma, and K.K. Khanna Molecular Oncology 11:470-490 (2017) |
| 2017 | MET signaling promotes DNA repair and radiation resistance in glioblastoma stem-like cells. Todorova PK, Mukherjee B, Burma S. Ann Transl Med. 2017 Feb;5(3):61. |
| 2017 | Prevalence of female genital tuberculosis, its risk factors and associated clinical features among the women of Andaman Islands, India: a community-based study. Parvez R, Sugunan AP, Vijayachari P, Burma SP, Mandal A, Saha MK, Shah WA. Public Health. 2017 Jul;148:56-62. |
| 2017 | Endonuclease EEPD1 is a gatekeeper for repair of stressed replication forks. H.S. Kim, J.A. Nickoloff, Y. Wu, E.A. Williamson, G.S. Sidhu, B.L. Reinert, A.S. Jaiswal, G. Srinivasan, B. Patel, K. Kong, S. Burma, S.H. Lee, and R.A. Hromas Journal of Biological Chemistry 292:2795-2804 (2017) |
| 2016 | INT6/EIF3E Controls the RNF8-Dependent Ubiquitylation Pathway and Facilitates DNA Double-Strand Break Repair in Human Cells. C. Morris, N. Tomimatsu, S. Burma, and P. Jalinot Cancer Research 76:6054-6065 (2016) |
| 2016 | Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma. C.R. Gil Del Alcazar, P.K. Todorova, A.A. Habib, B. Mukherjee, and S. Burma Molecular Cancer Research 14:928-940 (2016) Cover Image of Molecular Cancer Research October 2016 issue. Included in Molecular Cancer Research Must-Read 2016 |
| 2015 | EEPD1 Rescues Stressed Replication Forks and Maintains Genome Stability by Promoting End Resection and Homologous Recombination Repair. Y. Wu, S.H. Lee, E.A. Williamson, B.L. Reinert, J.H. Cho, F. Xia, A.S. Jaiswal, G. Srinivasan, B. Patel, A. Brantley, D. Zhou, L. Shao, R. Pathak, M. Hauer-Jensen, S. Singh, K. Kong, X. Wu, H.S. Kim, T.S. Beissbarth, J. Gaedcke, S. Burma, J.A. Nickoloff, and R.A. Hromas PLoS Genetics 11:e1005675 (2015) |
| 2015 | DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification. C.V. Camacho, P.K. Todorova, M.C. Gillam, N. Tomimatsu, C.R. Gil del Alcazar, M. Ilcheva, B. Mukherjee, B. McEllin, V. Vemireddy, K. Hatanpaa, M.D. Story, A.A. Habib, V.V. Murty, R. Bachoo, and S. Burma Oncogene 34:1064-72 (2015) |
| 2015 | Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. G. Chakrabarti, M.A. Silvers, M. Ilcheva, Y. Liu, Z.R. Moore, X. Luo, J. Gao, G. Anderson, L. Liu, V. Sarode, D.E. Gerber, S. Burma, R.J. DeBerardinis, S.L. Gerson, and D.A. Boothman Science Reports 5:17066 (2015) |
| 2014 | Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone. G. Chakrabarti, Z.R. Moore, X. Luo, M. Ilcheva, A. Ali, M. Padanad, Y. Zhou, Y. Xie, S. Burma, P.P. Scaglioni, L.C. Cantley, R.J. DeBerardinis, A.C. Kimmelman, C.A. Lyssiotis, and D.A Boothman Cancer Metabolism 3:12 (2015) |
| 2014 | Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice. N. Tomimatsu, B. Mukherjee, M. Gillam, M. Ilcheva, M.C. Hardebeck, C.V. Camacho, J.L. Harris, M. Porteus, B. Llorente, K.K. Khanna, and S. Burma Nature Communications 5:3561-71 (2014) |
| 2014 | Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma. C. Gil Del Alcazar, M. Gillam, B. Mukherjee, N. Tomimatsu, X. Gao, J. Yan, X.J. Xie, R. Bachoo, L. Li, A.A. Habib, and S. Burma Clinical Cancer Research 20:1235-48 (2014) |
| 2014 | An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII. L. Li, V.T. Puliyappadamba, S. Chakraborty, A. Rehman, V. Vemireddy, D. Saha, R.F. Souza, K.J. Hatanpaa, P. Koduru, S. Burma, D.A. Boothman, and A.A. Habib Oncogene 34:129-134 (2014) |
| 2013 | An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII. L. Li, S. Chakraborty, C.R. Yang, K.J. Hatanpaa, D.J. Cipher, V.T. Puliyappadamba, A. Rehman, A.J. Jiwani, B. Mickey, C. Madden, J. Raisanen, S. Burma, D. Saha, Z. Wang, S.C. Pingle, S. Kesari, D.A. Boothman, and A.A. Habib Oncogene 33:4253-64 (2014) |
| 2013 | Opposing effect of EGFRWT on EGFRvIII-mediated NF-κB activation with RIP1 as a cell death switch. V.T. Puliyappadamba, S. Chakraborty, S.S. Chauncey, L. Li, K.J. Hatanpaa, B. Mickey, S. Noorani, H.K. Shu, S. Burma, D.A. Boothman, and A.A. Habib Cell Reports 4:764-75 (2013) |
| 2012 | Cytoplasmic TRADD confers a worse prognosis in glioblastoma. S. Chakraborty, L. Li, H. Tang, Y. Xie, V.T. Puliyappadamba, J. Raisanen, S. Burma, D.A. Boothman, B. Cochran, J. Wu, and A.A. Habib Neoplasia 15:888-97 (2013) |
| 2012 | The yeast Fun30 and human SMARCAD1 chromatin remodellers promote DNA end resection. T. Costelloe*, R. Louge*, N. Tomimatsu*, B. Mukherjee, B. Khadaroo, K. Dubois, W. Wiegant, E. Martini, A. Thierry, S. Burma, H. van Attikum, and B. Llorente Nature 489:581-584 (2012) *equal contribution |
| 2012 | INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells. C. Morris, N. Tomimatsu, D.J. Richard, D. Cluet, S. Burma, K.K. Khanna, and P. Jalinot Cancer Research 72:2006-2016 (2012) |
| 2012 | Exo1 plays a major role in DNA end resection in humans and influences DNA repair and damage signaling decisions. N. Tomimatsu, B. Mukherjee, K. Deland, A. Kurimasa, E. Bolderson, K.K. Khanna, and S. Burma DNA Repair 11:441-448 (2012) |
| 2012 | The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses. B. Mukherjee, N. Tomimatsu, K. Amancherla, C.V. Camacho, N. Pichamoorthy, and S. Burma Neoplasia 14:34-43 (2012) |
| 2012 | Nucleolin Participates in DNA Double-Strand Break-Induced Damage Response through MDC1-Dependent Pathway. J. Kobayashi, H. Fujimoto, J. Sato, I. Hayashi, S. Burma, S. Matsuura, D.J. Chen, K. Komatsu PLoS One 7:e49245 (2012) |
| 2012 | AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells. P. Raghavan, V. Tumati, L. Yu, N. Chan, N. Tomimatsu, S. Burma, R.G. Bristow, and D. Saha Int. J. Radiation Oncology Biol. Phys. 84:507-5014 (2012) |
| 2010 | Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells. Z. Kong, P. Raghavan, D. Xie, T. Boike, S. Burma, D.J. Chen, A. Chakraborty, J-T. Hsieh and D. Saha Int. J. Radiation Oncology Biol. Phys. 78:250-257 (2010) |
| 2010 | Loss of p15/Ink4b accompanies tumorigenesis triggered by complex DNA double-strand breaks. C. V. Camacho, B. Mukherjee, B. McEllin, L-H. Ding, B. Hu, A. Habib, X-J. Xie, C. Nirodi, D. Saha, M. Story, A. Balajee, R. M. Bachoo, D. A. Boothman, and S. Burma Carcinogenesis 31:1889-1896 (2010) |
| 2010 | WRN participates in translesion synthesis pathway through interaction with NBS1. J. Kobayashi, M. Okui, A. Asaithamby, S. Burma, B. Chen, K. Tanimoto, S. Matsuura, K. Komatsu, D.J. Chen Mech Ageing Dev. 131:436-444 (2010) |
| 2010 | Down-regulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Z. Kong, D. Xie, T. Boike, P. Raghavan, S. Burma, D.J. Chen, A.A. Habib, A. Chakraborty, J-T. Hsieh and D. Saha Cancer Research 70:2829-2839 (2010) |
| 2010 | PTEN loss compromises homologous recombination repair in astrocytes: Implications for glioblastoma therapy with temozolomide or poly(ADP-Ribose) polymerase inhibitors. B. McEllin, C.V. Camacho, B. Mukherjee, B. Hahm, N. Tomimatsu, R.M. Bachoo, and S. Burma Cancer Research 70:5457-5464 (2010) |
| 2009 | RIP1 activates PI3K-Akt via a dual mechanism involving NF-κB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. S. Park, D. Zhao, K.J. Hatanpaa, B.E. Mickey, D. Saha, D.A. Boothman, M.D. Story, E.T. Wong, S. Burma, M-M. Georgescu, V.M. Rangnekar, S.S. Chauncey, and A.A. Habib Cancer Research 69:4107-4111 (2009) |
| 2009 | EGFRvIII and DNA double-strand break repair: A molecular mechanism for radioresistance in glioblastoma. B. Mukherjee, B. McEllin, C.V. Camacho, N. Tomimatsu, S. Sirasanagandala, S. Nannepaga, K.J. Hatanpaa, B. Mickey, C. Madden, E. Maher, D.A. Boothman, F. Furnari, W.K. Cavenee, R.M. Bachoo, and S. Burma Cancer Research 69:4252-4259 (2009) |
| 2009 | Histone H2AX participates the DNA damage-induced ATM activation through interaction with NBS1. J. Kobayashi, H. Tauchi, B. Chen, S. Burma, S. Tashiro, S. Matsuura, K. Tanimoto, D.J. Chen, K. Komatsu Biochem. Biphys. Res. Commun. 380:752-757 (2009) |
| 2009 | Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. N. Tomimatsu, B. Mukherjee, and S. Burma EMBO Reports 10:629-635 (2009) |
| 2009 | Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks. E. Bolderson, N. Tomimatsu, D.J. Richards, D. Boucher, R. Kumar, T.K. Pandita, S. Burma, K.K. Khanna Nucleic Acids Res. 38:1821-1831 (2009) |
| 2008 | Modulation of the DNA-damage response to HZE particles by shielding. B. Mukherjee, C.V. Camcho, N. Tomimatsu, J. Miller, and S. Burma DNA Repair 7:1717-1730 (2008) |
| 2008 | Repair of HZE-particle-induced DNA double-strand breaks in normal human fibroblasts. A. Asaithamby, N. Uematsu, A. Chatterjee, M.D. Story, S. Burma, and D.J. Chen Radiation Research 169:437-446 (2008) |
| 2007 | Ku70/80 modulates ATM and ATR signaling pathways in response to DNA double strand breaks.N. Tomimatsu, G.G. Tahimic, A. Otsuki, S. Burma, A. Fukuhara, K. Sato, G. Shiota, M. Oshimura, D.J. Chen, and A. Kurimasa Journal of Biological Chemistry 282:10138-10145 (‘07) |
| 2007 | Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability. J. Li, D.P. Sejas, S. Burma, D.J. Chen, and Q. Pang Carcinogenesis 28:1163-1170 (2007) |
| 2006 | DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. B. Mukherjee, C. Kessinger, J. Kobayashi, B.P. Chen, D.J. Chen, A. Chatterje, and S. Burma DNA Repair 5:575-590 (2006) |
| 2006 | Effect of Ku proteins on IRES-mediated translation. D. Silvera, N. Koloteva-Levine, S. Burma, and O. Elroy-Stein Biology of the Cell 98:353-361 (2006) |
| 2005 | Gene expression profiles of normal human fibroblasts after exposure to ionizing radiation: A comparative study of low and high doses. L.-H. Ding, M. Shingyoji, F. Chen, J.-J. Hwang, S. Burma, J.-F. Cheng, and D. J. Chen Radiation Research 164:17-26 (2005) |
| 2005 | Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. B. Chen, D.W. Chan, J. Kobayashi, S. Burma, A. Asaithamby, K. Morotomi-Yano, E. Botvinick, J. Qin, and D.J. Chen Journal of Biological Chemistry 280:14709-14715 (2005) |
| 2004 | Amplification and overexpression of oncogene Mdm2 and orphan receptor gene Nr1h4 in immortal PRKDC knockout cells. R. Ai, A. Sandoval, D.J. Chen, S. Burma, and P. Labhart Molecular Biology Reports 31:91-96 (2004) |
| 2003 | Lethality in PARP-1/Ku80 double mutant mice reveals physiological synergy during early embryogenesis. M.S. Henrie, A. Kurimasa, S.Burma, J. Menissier-de Murcia, G. de Murcia, G.C. Li, and D.J. Chen DNA Repair 2:151-158 (2003) |
| 2002 | DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53. R.A. Woo, M.T. Jack, Y. Xu, S. Burma, D.J. Chen, and P.W. Lee EMBO Journal 21:3000-3008 (2002) |
| 2002 | Differing responses of Nijmegen breakage syndrome and ataxia telangiectasia cells to ionizing radiation. J. Little, H. Nagasawa, W.K. Dahlberg, M.Z. Zdzienicka, S. Burma , and D.J.Chen Radiation Research 158:319-326 (2002) |
| 2001 | ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks. S. Burma, B.P. Chen, M. Murphy, A. Kurimasa, and D.J. Chen Journal of Biological Chemistry 276:42462-42467 (2001) “Of outstanding interest”-Current Opinions in Genetics & Development (2002), Citations > 1,100 |
| 1999 | DNA-dependent protein kinase-independent activation of p53 in response to DNA damage.S. Burma, A. Kurimasa, G. Xie, Y. Taya, R. Araki, H.A. Crissman, M. Abe, H. Ouyang, G.C. Li, and D.J. Chen Journal of Biological Chemistry 274:17139-17143 (1999) |
| 1999 | Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA- dependent protein kinase catalytic subunit-deficient cells. R. Araki, R. Fukumura, A. Fujimori, Y. Taya, Y. Shiloh, A. Kurimasa, S. Burma, G.C. Li, D.J. Chen, K. Satoh, Y. Hoki, K. Tatsumi, and M. Abe Cancer Research 59:3543-3546 (1999) |
| 1999 | TFIIA regulates TBP and TFIID dimers. R.A. Coleman, A.K. Taggart, S. Burma, J.J. Chicca 2nd, and B.F. Pugh Molecular Cell 4:451-457 (1999) |
| 1999 | Dimer dissociation and thermosensitivity kinetics of the Saccharomyces cerevisiae and human TATA binding proteins. *A.J. Jackson-Fisher, *S. Burma, *M. Portnoy, L.A. Schneeweis, R.A. Coleman, M. Mitra, C. Chitikila, and B.F. Pugh Biochemistry 38:11340-11348 (1999) [*Equal contribution] |
| 1998 | Increase in p202 expression during skeletal muscle differentiation: Inhibition of MyoD protein expression and activity by p202. B. Datta, W. Min, S. Burma, and P. Lengyel Molecular and Cellular Biology 18:1074-1083 (1998) |
| 1996 | Bifunctionality of the AcMNPV homologous region sequence (hr1): Enhancer and ori functions have different sequence requirements. S. Habib, S. Pandey, U. Chatterjee, S. Burma, R. Ahmed, A. Jain, and S.E. Hasnain DNA and Cell Biology 15:737-747 (1996) |
| 1995 | Transcriptional Regulation of Cell Line-Dependent, Baculovirus-Mediated Expression of Foreign Genes. B. Mukherjee, S. Burma, G.P. Talwar, and S.E. Hasnain DNA and Cell Biology 14:7-14 (1995) |
| 1995 | The 30-kDa protein binding to the "initiator" of the baculovirus polyhedrin promoter also binds specifically to the coding strand. B. Mukherjee, S. Burma, and S. E. Hasnain Journal of Biological Chemistry 270:4405-4411 (1995) |
| 1994 | An unusual 30-kDa protein binding to the polyhedrin gene promoter of Autographa californica nuclear polyhedrosis virus. S. Burma, B. Mukherjee, A. Jain, S. Habib, and S.E. Hasnain Journal of Biological Chemistry 269:2750-2757 (1994) |
